Standout Papers

Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Pa... 2021 2026 2022 2024260
  1. Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19：a meta-analysis (2022)
    Wen Wen, Chen Chen et al. Annals of Medicine
  2. Anxiety, depression, and stress prevalence among college students during the COVID-19 pandemic: A systematic review and meta-analysis (2021)
    Chunyi Wang, Wen Wen et al. Journal of American College Health

Immediate Impact

58 standout
Sub-graph 1 of 24

Citing Papers

Metabolic-associated fatty liver disease: a selective review of pathogenesis, diagnostic approaches, and therapeutic strategies
2024 Standout
Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19
2024 Standout
1 intermediate paper

Works of Xingwei Zhang being referenced

Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19：a meta-analysis
2022 Standout
Metabolic dysfunction-associated fatty liver disease and cardiovascular disease: A meta-analysis
2022

Author Peers

Author Last Decade Papers Cites
Xingwei Zhang 109 63 102 210 147 60 813
Jonas Christoffer Lindstrøm 66 35 104 101 135 52 896
Gülay Sain Güven 94 83 122 85 75 48 715
Yoshito Nishimura 119 56 311 102 170 109 935
Siddhartha Dutta 141 64 52 407 106 66 926
Saibal Das 49 44 37 195 94 83 957
Meseret Derbew Molla 56 69 61 151 141 46 850
Giuseppe Lisco 76 64 52 175 57 70 906
Xiangning Yuan 74 29 82 232 67 26 835
Christian Bime 75 56 59 147 66 51 956
Mengyun Zhou 49 28 69 327 173 42 876

All Works

Loading papers...

Rankless by CCL
2026